|
|
MicroDose Technologies, Inc. is a privately held premier drug delivery and specialty pharmaceuticals company. Founded in 1998, MicroDose is pioneering the use of proprietary drug delivery platforms for the pulmonary, oral and transdermal delivery of medications for improved efficacy and compliance. MicroDose's current focus is on the chronic disease states such as asthma, COPD, diabetes, hypertension and hyperlipidemia. Mission Statement To improve the quality of life for people suffering from chronic diseases by creating improved pharmaceutical products through the application of proprietary drug delivery technologies. |
MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under |
||
Please visit our User Agreement. Your continued use of this site will automatically constitute your agreement to be bound by all the terms and conditions of the User Agreement. ©2004 MicroDose Technologies, Inc. |